Literature DB >> 21477716

Barriers and facilitators to digital rectal examination screening among African-American and African-Caribbean men.

Daniel J Lee1, Nathan S Consedine, Benjamin A Spencer.   

Abstract

OBJECTIVES: To examine the effect of race/ethnicity and fear characteristics on the initiation and maintenance of digital rectal examination (DRE) screening.
METHODS: A total of 533 men from Brooklyn, New York, aged 45-70 years, were classified into 4 race/ethnic groups: U.S.-born whites, U.S.-born African-American, Jamaican, and Trinidadian/Tobagonian. The participants recorded the number of DREs in the past 10 years. The demographics and structural variables and prostate cancer worry and screening fear were measured using validated tools.
RESULTS: Overall, 30% of subjects reported never having a DRE, and 24% reported annual DREs. African-American, Jamaican, and Trinidadian/Tobagonian men had greater prostate cancer worry and screening fear scores than did the white men (all P < .05). African-American, Jamaican, and Trinidadian/Tobagonian men were less likely to maintain annual DREs than white men (odds ratio 0.17, 0.26, and 0.16, respectively, all P < .05). The men with low screening fear were more likely to have had an initial DRE (OR 2.3, P < .05 vs high screening fear) but were no more or less likely to undergo annual DREs. Having a regular physician, comprehensive physician discussion, and annual visits were also associated with undergoing DREs.
CONCLUSIONS: We identified several ethnically varying barriers and facilitators to DRE screening. African-American and African-Caribbean men undergo DRE less often and have greater prostate cancer worry and screening fear scores than did white men. Screening fear predicts the likelihood of undergoing an initial, but not annual, DRE screening. Access to a physician and annual visits facilitate DRE screening. Interventions that include both culturally sensitive education and patient navigation and considered whether patients should be initiating or maintaining screening might facilitate guideline-consistent screening.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21477716      PMCID: PMC3092791          DOI: 10.1016/j.urology.2010.11.056

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  28 in total

1.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

2.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

3.  Prostate specific antigen best practice statement: 2009 update.

Authors:  Kirsten L Greene; Peter C Albertsen; Richard J Babaian; H Ballentine Carter; Peter H Gann; Misop Han; Deborah Ann Kuban; A Oliver Sartor; Janet L Stanford; Anthony Zietman; Peter Carroll
Journal:  J Urol       Date:  2009-09-24       Impact factor: 7.450

4.  Prostate cancer screening behavior in men from seven ethnic groups: the fear factor.

Authors:  Nathan S Consedine; Amy H Morgenstern; Elizabeth Kudadjie-Gyamfi; Carol Magai; Alfred I Neugut
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

Review 5.  A framework for the identification of men at increased risk for prostate cancer.

Authors:  Monique J Roobol; Fritz H Schröder; E David Crawford; Stephen J Freedland; A Oliver Sartor; Neil Fleshner; Gerald L Andriole
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

6.  Cancer incidence and mortality in the Caribbean.

Authors:  Adrienne A Phillips; Judith S Jacobson; Carol Magai; Nathan Consedine; Nathalie C Horowicz-Mehler; Alfred I Neugut
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

7.  Barriers to the initiation and maintenance of prostate specific antigen screening in Black American and Afro-Caribbean men.

Authors:  Joshua R Gonzalez; Nathan S Consedine; James M McKiernan; Benjamin A Spencer
Journal:  J Urol       Date:  2008-10-18       Impact factor: 7.450

8.  Fear, knowledge, and efficacy beliefs differentially predict the frequency of digital rectal examination versus prostate specific antigen screening in ethnically diverse samples of older men.

Authors:  Nathan S Consedine; David Horton; Tracey Ungar; Andrew K Joe; Paul Ramirez; Luisa Borrell
Journal:  Am J Mens Health       Date:  2007-03

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 10.  The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.

Authors:  Fritz Schröder; Michael W Kattan
Journal:  Eur Urol       Date:  2008-05-22       Impact factor: 20.096

View more
  13 in total

Review 1.  Beyond the black box: a systematic review of breast, prostate, colorectal, and cervical screening among native and immigrant African-descent Caribbean populations.

Authors:  Nathan S Consedine; Natalie L Tuck; Camille R Ragin; Benjamin A Spencer
Journal:  J Immigr Minor Health       Date:  2015-06

2.  A phase II clinical study to assess the feasibility of self and partner anal examinations to detect anal canal abnormalities including anal cancer.

Authors:  Alan G Nyitray; Joseph T Hicks; Lu-Yu Hwang; Sarah Baraniuk; Margaret White; Stefanos Millas; Nkechi Onwuka; Xiaotao Zhang; Eric L Brown; Michael W Ross; Elizabeth Y Chiao
Journal:  Sex Transm Infect       Date:  2017-08-23       Impact factor: 3.519

3.  Ethnic Differences Among Black Men in Prostate Cancer Knowledge and Screening: a Mixed-Methods Study.

Authors:  Nipher Malika; Lisa Roberts; Qais Alemi; Carlos A Casiano; Susanne Montgomery
Journal:  J Racial Ethn Health Disparities       Date:  2021-03-30

Review 4.  Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review.

Authors:  Erica G Bromley; Folasade P May; Lisa Federer; Brennan M R Spiegel; Martijn G H van Oijen
Journal:  Prev Med       Date:  2014-12-04       Impact factor: 4.018

5.  Factors associated with prostate cancer screening behavior among men over 50 in Fasa, Iran, based on the PRECEDE model.

Authors:  Ali Khani Jeihooni; Seyyed Mansour Kashfi; Seyyed Hannan Kashfi; Akbar Babaei Heydarabadi; Masoumeh Imanzad; Asghar Ashrafi Hafez
Journal:  Electron Physician       Date:  2015-06-05

Review 6.  Men's perspectives of prostate cancer screening: A systematic review of qualitative studies.

Authors:  Laura J James; Germaine Wong; Jonathan C Craig; Camilla S Hanson; Angela Ju; Kirsten Howard; Tim Usherwood; Howard Lau; Allison Tong
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

7.  The diagnostic test accuracy of rectal examination for prostate cancer diagnosis in symptomatic patients: a systematic review.

Authors:  Daniel Jones; Charlotte Friend; Andreas Dreher; Victoria Allgar; Una Macleod
Journal:  BMC Fam Pract       Date:  2018-06-02       Impact factor: 2.497

Review 8.  Rethinking prostate cancer screening: could MRI be an alternative screening test?

Authors:  David Eldred-Evans; Henry Tam; Heminder Sokhi; Anwar R Padhani; Mathias Winkler; Hashim U Ahmed
Journal:  Nat Rev Urol       Date:  2020-07-21       Impact factor: 14.432

9.  The structure and demographic correlates of cancer fear.

Authors:  Charlotte Vrinten; Cornelia H M van Jaarsveld; Jo Waller; Christian von Wagner; Jane Wardle
Journal:  BMC Cancer       Date:  2014-08-16       Impact factor: 4.430

10.  Prostate Cancer Screening in Jamaica: Results of the Largest National Screening Clinic.

Authors:  Belinda F Morrison; William Aiken; Richard Mayhew; Yulit Gordon; Marvin Reid
Journal:  J Cancer Epidemiol       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.